Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
The Medical Journal of Australia|November 5, 2019
Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trialN Wah Cheung, Lesley V Campbell, Gregory R Fulcher, et al.
Clinical Endocrinology|October 3, 2024
Adrenal Vein Sampling for Primary Aldosteronism: Recommendations From the Australian and New Zealand Working GroupJun Yang, Damon A Bell, Richard Carroll, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 7, 2015
Research Priorities in CKD: Report of a National Workshop Conducted in AustraliaAllison Tong, Sally Crowe, Shingisai Chando, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 23, 2025
Implementation of Established Global Guidelines in the Management of CKD in Patients with Type 2 Diabetes in AsiaRajiv Agarwal, Masaomi Nangaku, Liming Chen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 23, 2021
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria: A CREDENCE Secondary AnalysisMeg Jardine, Zien Zhou, Hiddo J Lambers Heerspink, et al.
Journal of the American Society of Nephrology : JASN|May 2, 2020
Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized TrialMeg J Jardine, Zien Zhou, Kenneth W Mahaffey, et al.
The New England Journal of Medicine|April 17, 2019
Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyVlado Perkovic, Meg J Jardine, Bruce Neal, et al.
Circulation|July 12, 2019
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention GroupsKenneth W Mahaffey, Meg J Jardine, Severine Bompoint, et al.
Circulation|February 8, 2021
Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE TrialNan Ye, Meg J Jardine, Megumi Oshima, et al.
Lancet (London, England)|April 25, 2017
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policyAdeera Levin, Marcello Tonelli, Joseph Bonventre, et al.
Pageof 16